Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC Through Liquid Biopsy Integration
About this study
Implementation of a new algorithm for HRR gene mutation testing in patients with mPC through liquid biopsy integration
- Condition
- Metastatic Prostate Cancer (mPC)
- Sponsor
- European Institute of Oncology
Who can join
- Age
- 18 years and older
- Sex
- Male only
- Healthy volunteers
- Not accepted
Inclusion 4
- Minimum age: 18 years
- Eligible sex: Male
- Study condition: Metastatic Prostate Cancer (mPC)
- Patients with metastatic prostate cancer whose tumor tissue is unavailable or inadequate for molecular testing. • Written informed consent must be signed and dated by the patient and the investigator prior to inclusion.
Exclusion 1
- Unable to provide written informed consent
Where
1 site, 1 recruiting
European Institute of oncology
Milan, Italy, Italy
Contact
-
Elena Guerini Rocco, MD
00390294372871 elena.guerinirocco@ieo.it
-
francesca lombardi, biologist
00390257489425 francesca.lombardi@ieo.it
Potential match only. Final eligibility is determined by the study team.